Non-antiarrhythmic drugs for the prevention of atrial fibrillation: ACEIs, ARBs, statins and PUFAs
Fauchier, L.; Pierre, B.; Clementy, N.; Babuty, D.
Le Journal Medical Libanais. Lebanese Medical Journal 61(2): 105-108
2013
ISSN/ISBN: 0023-9852 PMID: 24163897 Document Number: 666672
Document emailed within 1 workday
Related Documents
Alboni, P.; Gianfranchi, L.; Pacchioni, F.; Pedaci, M. 2005: Antiarrhythmic drugs in patients with recurrent atrial fibrillation: where are we? Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(3): 169-174Wu, G.; Jiang, H.; Huang, C.-x.; Yang, B.; Huang, H.; Wang, Y.-l.; Wang, X.-h.; Liu, H.-f.; Yang, X.-h. 2008: Effects of antiarrhythmic drug use on atrial fibrillation recurrence in atrial fibrillation patients post circumferential pulmonary vein ablation Zhonghua Xin Xue Guan Bing Za Zhi 36(7): 623-626
Walczak, F.; Szumowski, Łu.; Urbanek, P.; Szufladowicz, E.; Bodalski, R.; Kuśmierczyk, B.; Maryniak, A.; Baranowski, R.ł; Kepski, R.; Bujnowska, E. 2004: Significance of the origin of the right upper pulmonary vein and antiarrhythmic agents in transformation of long-lasting atrial fibrillation to unsustained but repetitive atrial flutter or atrial tachycardia Kardiologia Polska 60(4): 407-414
Carlsson, A.C.; Wändell, P. 2014: Is it time for regular prescription of statins in atrial fibrillation? Lakartidningen 111(48): 2170
Vijan, S.G. 2009: Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients Journal of the Indian Medical Association 107(3): 178-182
Cherednik, I.L.; Sheikh-Zade, I.R.; Galenko-Iaroshevskiĭ, P.A.; Stodolia, G.A. 1999: Comparative evaluation of antiarrhythmic effects of methacizine and its components during neurogenic atrial fibrillation Biulleten' Eksperimental'noi Biologii i Meditsiny 128(9): 291-293
Gulløv, A.L.; Koefoed, B.G.; Petersen, P.; Pedersen, T.S.; Andersen, E.D.; Godtfredsen, J.; Boysen, G. 1998: Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study Archives of Internal Medicine 158(14): 1513-1521
Cargnelli, G.; Domeneghetti, F.; Ferrari, M.; Malacini, P.; Roberti, G. 1977: Plasma digoxin concentrations in patients with atrial fibrillation and indications for the association with other antiarrhythmic agents International Journal of Clinical Pharmacology and Biopharmacy 15(8): 384-388
He, R.; Du, X.; Liu, S.W.; Sun, L.J.; Li, Y.; Zeng, H.; Li, Y.Y.; Sun, C.; Zhang, Y.; Ma, C.S.; Gao, W. 2016: Current status of antiarrhythmic drug use and safety assessment in Chinese patients with atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 44(11): 935-939
Kanorskiĭ, S.G. 2014: Antiarrhythmic therapy in patients with paroxysmal and persistent atrial fibrillation: identification of achievable goals and assessment of available funds Kardiologiia 54(2): 70-74
Cox, J.L.; Schuessler, R.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. I. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 402-405
Gancarczyk, U.; Przewłocki, T.; Podolec, P.; Komar, M. 2019: Elimination of the left atrial appendage in the prevention of thromboembolic events in patients with atrial fibrillation Wiadomosci Lekarskie 72(9 Cz 2): 1829-1833
Einecke, D. 2013: Stroke prevention in atrial fibrillation: atrial appendage occlusion again proves to be safe and effective MMW Fortschritte der Medizin 155 Spec no 1(1): 24
McCauley, B.D.; Chu, A.F. 2017: Minimally Invasive Closure of the Left Atrial Appendage: A Non-Pharmacologic Approach to Prevention of Stroke in Patients with Atrial Fibrillation Rhode Island Medical Journal 100(5): 23-26
Lerakis, S.; Synetos, A. 2008: Left atrial appendage exclusion system for stroke prevention in atrial fibrillation: a percutaneous device delivery approach Minerva Cardioangiologica 56(6): 667-670
Jalil, E.; Mensour, B.; Vinet, A.; Kus, T. 2003: Excitable gap composition in the presence of antiarrhythmic drugs in common human atrial flutter Canadian Journal of Cardiology 19(3): 244-248
Cox, J.L.; Canavan, T.E.; Schuessler, R.B.; Cain, M.E.; Lindsay, B.D.; Stone, C.; Smith, P.K.; Corr, P.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 406-426
Jazwinska-Tarnawska, E.; Orzechowska-Juzwenko, K.; Niewinski, P.; Rzemislawska, Z.; Loboz-Grudzien, K.; Dmochowska-Perz, M.; Slawin, J. 2001: The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment International Journal of Clinical Pharmacology and Therapeutics 39(7): 288-292
Ertas, F.; Oylumlu, M.; Akil, M.A.; Acet, H.; Bilik, M.Z.; Celepkolu, T.; Yildiz, A.; Kaya, H.; Alan, S.; Ozhan, H. 2013: Non-valvular atrial fibrillation in the elderly; preliminary results from the National AFTER (Atrial Fibrillation in Turkey: Epidemiologic Registry) Study European Review for Medical and Pharmacological Sciences 17(8): 1012-1016
Hidden-Lucet, F.ço. 2002: Antithrombotic drugs in atrial fibrillation La Revue du Praticien 52(12): 1324-1328